Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection charts are the FTSE 100, Alkemy, Berkeley, Capital Metals,
RNS Hotlist with Zak Mir: HUI, PALM, 88E, VAL, DDDD, PEN, TERN & EST via Vox Markets
Hydrogen Utopia International (HUI), a company pioneering non-recyclable waste plastics to hydrogen technology, updated as to the implications of the current invasion of Ukraine by Russia.
4d Pharma PLC (AIM:DDDD) MRx0518 + Keytruda – Primary endpoint met in RCC
4D pharma Announces Positive Interim Results from the Phase I/II Study of the Combination of MRx0518 and KEYTRUDA® (pembrolizumab) for the Treatment of Renal Cell Carcinoma
Traders Cafe with Zak Mir: Bulletin Board Heroes, Monday 14th March 2022 via Vox Markets
Zak Mir takes a charting look at some of the most followed small caps on the London stock market. Today’s selection includes Berkeley, Bluerock, Cloudbreak, 4D, Egdon, Hemogenyx, Igas, Neometals,
Share Talk Weekly Stock Market News, Sunday 27th February 2022.
The market recovered on Friday after rising tensions over Russia and Ukraine caused share prices on the FTSE 100 to drop dramatically on Thursday.
4d Pharma PLC (AIM: DDDD) Participation in Chardan Microbiome Summit
4D pharma to Participate at the Chardan Metagenomics and Microbiome Medicines Summit
4d Pharma PLC (AIM: DDDD) Parkinson’s trial receives FDA IND clearance
4D pharma announces FDA clearance of IND application for Live Biotherapeutics MRx0005 and MRx0029 for the treatment of Parkinson’s disease
RNS Hotlist with Zak Mir: ORCP, OKYO, LIFE, TGR, ANIC, PDL, GLR, BIDS, YU., VRS, THG, BRES, THR, OCTP, TM1, AXL, DDDD & PYX
The positive newsflow keeps on coming for Open Orphan (ORPH), the specialist contract research organisation.
4d Pharma PLC (AIM: DDDD) Restatement of Interim Results to June 30, 2021
4D pharma to Restate Unaudited Interim Financial Statements for the Six-Month Period Ended June 30, 2021 to Correct Accounting for Warrants
RNS Hotlist with Zak Mir: OKYO, CHLL, UOG, CGNR, HAYD, EML, TRR, ALS, AXL, DDDD, CSFS & PXEN via Vox Markets
After yesterday’s RNS from OKYO Pharma (OKYO), a biotechnology company, there was some leading from the front by Gabriele Cerrone, the Executive Chairman. He purchased 200,000 ordinary shares 5p and
4d Pharma PLC (DDDD.L) Appoints John Doyle as Chief Financial Officer
Leeds, UK, January 4, 2022, – 4D pharma plc (AIM: DDDD, NASDAQ: LBPS), a pharmaceutical company leading the development of Live Biotherapeutic Products (LBPs), a novel class of drug derived
4d Pharma PLC (DDDD.L) Phase 1/2 asthma study Part A results
4D pharma announces positive topline results from Part A of Phase I/II trial of MRx-4DP0004 for the treatment of asthma